The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Biosensors: the new wave in cancer diagnosis
Open accessAbstract
The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Carbon‐Nanotube Based Electrochemical Biosensors: A Review
Wang, J. (2005) · Electroanalysis · doi:10.1002/elan.200403113 · Cited by 2,387
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Encyclopedia of food sciences and nutrition
Caballero, B. H., Trugo, L. C., & Finglas, P. M. (2003) · Academic eBooks · Cited by 1,639
Electrochemical biosensors: Towards point-of-care cancer diagnostics
Wang, J. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2005.10.027 · Cited by 1,454
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Chen, Y.-T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
Mining the plasma proteome for cancer biomarkers
Hanash, S. M., Pitteri, S. J., & Faca, V. M. (2008) · Nature · doi:10.1038/nature06916 · Cited by 891
Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Carbon Nanotube Amplification Strategies for Highly Sensitive Immunodetection of Cancer Biomarkers
Yu, X., Munge, B., Patel, V., Jensen, G., Bhirde, A., Gong, J. D., Kim, S. N., Gillespie, J., Gutkind, J. S., Papadimitrakopoulos, F., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062117e · Cited by 686
A Whole Blood Immunoassay Using Gold Nanoshells
Hirsch, L. R., Jackson, J. B., Lee, A., Halas, N. J., & West, J. L. (2003) · Analytical Chemistry · doi:10.1021/ac0262210 · Cited by 676
Biosensors for cancer markers diagnosis
Tothill, I. E. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.01.015 · Cited by 552
Targeting quantum dots to surface proteins in living cells with biotin ligase
Howarth, M., Takao, K., Hayashi, Y., & Ting, A. Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503125102 · Cited by 552
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?
Duffy, M. J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.059832 · Cited by 460
Carbon nanotube-enhanced electrochemical DNA biosensor for DNA hybridization detection
Cai, H., Cao, X., Jiang, Y., He, P., & Fang, Y. (2003) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-002-1652-9 · Cited by 431
Origin of nanomechanical cantilever motion generated from biomolecular interactions
Wu, G., Ji, H., Hansen, K., Thundat, T., Datar, R., Cote, R., Hagan, M. F., Chakraborty, A. K., & Majumdar, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1560 · Cited by 415
Applications of Nanobiotechnology in Clinical Diagnostics
Jain, K. K. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.090795 · Cited by 381
Current issues in ER and HER2 testing by IHC in breast cancer
Gown, A. M. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.34 · Cited by 374
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2843 · Cited by 353
Noninvasive Glucose Monitoring: Comprehensive Clinical Results
Tamada, J. A., Garg, S., Jovanovic, L., Pitzer, K. R., Fermi, S., Potts, R. O., & and the Cygnus Research Team (1999) · JAMA · doi:10.1001/jama.282.19.1839 · Cited by 282
Dysregulation of apoptosis in hepatocellular carcinoma cells
Fabregat, I. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.513 · Cited by 280
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1174 · Cited by 276
Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker, C., Millar, D., Paul, C. L., Warnecke, P. M., Harrison, E. M., Vincent, P., Frommer, M., & Clark, S. J. (1997) · PubMed · Cited by 272
Label-free direct detection of MiRNAs with silicon nanowire biosensors
Zhang, G.-J., Chua, J. H., Chee, R.-E., Agarwal, A., & Wong, S. M. (2009) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.12.035 · Cited by 265
Biosensor Recognition Elements
(2008) · Current Issues in Molecular Biology · doi:10.21775/cimb.010.001 · Cited by 264
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
Kui Wong, N., Easton, R. L., Panico, M., Sutton-Smith, M., Morrison, J. C., Lattanzio, F. A., Morris, H. R., Clark, G. F., Dell, A., & Patankar, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302741200 · Cited by 238
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.
Bharali, D. J., Khalil, M., Gurbuz, M., et al. (2009) · PubMed · Cited by 238
Jäger, E., Stockert, E., Zidianakis, Z., Chen, Y.-T., Karbach, J., Jäger, D., Arand, M., Ritter, G., Old, L. J., & Knuth, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<506::aid-ijc10>3.0.co;2-6 · Cited by 227
Development of biosensors for cancer clinical testing
Rasooly, A., & Jacobson, J. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.01.003 · Cited by 200
Pencil-based renewable biosensor for label-free electrochemical detection of DNA hybridization
Wang, J., & Kawde, A.-N. (2001) · Analytica Chimica Acta · doi:10.1016/s0003-2670(00)01318-0 · Cited by 191
Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma
Greger, V., Debus, N., Lohmann, D., H�pping, W., Passarge, E., & Horsthemke, B. (1994) · Human Genetics · doi:10.1007/bf00211013 · Cited by 184
Cellular impedance biosensors for drug screening and toxin detection
Asphahani, F., & Zhang, M. (2007) · The Analyst · doi:10.1039/b704513a · Cited by 182
Koschwanez, H. E., & Reichert, W. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.034 · Cited by 181
Nanotechnology for cancer diagnostics: promises and challenges
Grodzinski, P., Silver, M., & Molnar, L. K. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.3.307 · Cited by 180
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
Mousa, S., Bharali, D., Khalil, M., Gurbuz, M., & Simone (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4241 · Cited by 162
Self-citationTumor markers in the management of patients with ovarian cancer
Tuxen, M. K., Sölétormos, G., & Dombernowsky, P. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90002-0 · Cited by 160
Prostate-specific antigen in the early detection of prostate cancer
Thompson, I. M., & Ankerst, D. P. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060955 · Cited by 155
The cancer antigen CA125 represents a novel counter receptor for galectin-1
Seelenmeyer, C., Wegehingel, S., Lechner, J., & Nickel, W. (2003) · Journal of Cell Science · doi:10.1242/jcs.00312 · Cited by 144
Jäger, D., Stockert, E., Gure, A. O., Scanlan, M. J., Karbach, J., Jäger, E., Knuth, A. K., Old, L. J., & Chen, Y. (2001) · PubMed · Cited by 131
Bassil, C. F., Zhao, Y., Zavaglia, K. M., Jin, P., Panelli, M. C., Voiculescu, S. E., Mandruzzato, S., Lee, H. M., Seliger, B., Freedman, R. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3433 · Cited by 127
Identification and Characterization of a Novel Cancer/Testis Antigen Gene CAGE
Cho, B., Lim, Y., Lee, D.-Y., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6701 · Cited by 115
Chan, L. L., Gosangari, S. L., Watkin, K. L., & Cunningham, B. T. (2007) · APOPTOSIS · doi:10.1007/s10495-006-0031-y · Cited by 110
Simpson, K., Whetton, A. D., & Dive, C. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.11.023 · Cited by 94
Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.
Falette, N., Paperin, M.-P., Treilleux, I., Gratadour, A.-C., Peloux, N., Mignotte, H., Tooke, N., Löfman, E., Inganäs, M., Bremond, A. G., et al. (1998) · PubMed · Cited by 82
Jia, Y., Qin, M., Zhang, H., et al. (2007) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2007.01.018 · Cited by 82
Detection of clinically relevant point mutations by a novel piezoelectric biosensor
Dell’Atti, D., Tombelli, S., Minunni, M., & Mascini, M. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2005.11.023 · Cited by 75
Advanced proteomic technologies for cancer biomarker discovery
Wong, S. C. C., Chan, C. M. L., Ma, B. B. Y., Lam, M. Y. Y., Choi, G. C. G., Au, T. C. C., Chan, A. S. K., & Chan, A. T. �. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.1 · Cited by 63
Epigenetic change in pituitary tumorigenesis.
Farrell, W. E., & Clayton, R. N. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100323 · Cited by 55
Proteomic technology for biomarker profiling in cancer: an update
Alaoui‐Jamali, M. A., & Xu, Y. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0411 · Cited by 54
Neesham, D. (2007) · PubMed · Cited by 38
BRCA1, Hormone, and Tissue-Specific Tumor Suppression
Hu, Y. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.20 · Cited by 34
Prostate Specific Antigen (PSA)
Anitz, J. H. H. (1993) · Disease Markers · doi:10.1155/1993/192831 · Cited by 32
Oncogenes and tumor suppressor genes
Liu, E., & Weissman, B. E. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3088-6_1 · Cited by 11
Cited by
Electrically-Transduced Chemical Sensors Based on Two-Dimensional Nanomaterials
Meng, Z., Stolz, R. M., Mendecki, L., & Mirica, K. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00311 · Cited by 773
Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers
Shin, H., Choi, B. H., Shim, O., Kim, J., Park, Y., Cho, S. K., Kim, H. K., & Choi, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-37403-1 · Cited by 402
Applications of carbon-based conductive nanomaterials in biosensors
Eivazzadeh-Keihan, R., Bahojb Noruzi, E., Chidar, E., Jafari, M., Davoodi, F., Kashtiaray, A., Ghafori Gorab, M., Masoud Hashemi, S., Javanshir, S., Ahangari Cohan, R., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.136183 · Cited by 365
Tîlmaciu, C.-M., & Morris, M. C. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00059 · Cited by 352
Diagnostic biosensors in medicine – A review
Metkar, S. K., & Girigoswami, K. (2019) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2018.11.029 · Cited by 304
Metadata
- Authors
- Mousa, S.
- Venue
- Nanotechnology, Science and Applications
- Publisher
- Informa UK Limited
- Published
- 2010-12
- Volume
- 4
- Pages
- 1
- ISSN
- 1177-8903 (ISSN-L)
- OpenAlex
- W2163364562
- Cited by
- 381
- References
- 54
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.